Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis.

TGF-β is essential for vascular development; however, excess TGF-β signaling promotes thoracic aortic aneurysm and dissection in multiple disorders, including Marfan syndrome. Since the pathology of TGF-β overactivity manifests primarily within the arterial media, it is widely assumed that suppression of TGF-β signaling in vascular smooth muscle cells will ameliorate aortic disease. We tested this hypothesis by conditional inactivation of Tgfbr2, which encodes the TGF-β type II receptor, in smooth muscle cells of postweanling mice. Surprisingly, the thoracic aorta rapidly thickened, dilated, and dissected in these animals. Tgfbr2 disruption predictably decreased canonical Smad signaling, but unexpectedly increased MAPK signaling. Type II receptor-independent effects of TGF-β and pathological responses by nonrecombined smooth muscle cells were excluded by serologic neutralization. Aortic disease was caused by a perturbed contractile apparatus in medial cells and growth factor production by adventitial cells, both of which resulted in maladaptive paracrine interactions between the vessel wall compartments. Treatment with rapamycin restored a quiescent smooth muscle phenotype and prevented dissection. Tgfbr2 disruption in smooth muscle cells also accelerated aneurysm growth in a murine model of Marfan syndrome. Our data indicate that basal TGF-β signaling in smooth muscle promotes postnatal aortic wall homeostasis and impedes disease progression.

[1]  D. Milewicz,et al.  Smooth muscle hyperplasia due to loss of smooth muscle α-actin is driven by activation of focal adhesion kinase, altered p53 localization and increased levels of platelet-derived growth factor receptor-β. , 2013, Human molecular genetics.

[2]  Paul Coucke,et al.  Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAAD. , 2013, International journal of cardiology.

[3]  M. Tassabehji,et al.  Rapamycin Inhibits Smooth Muscle Cell Proliferation and Obstructive Arteriopathy Attributable to Elastin Deficiency , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[4]  P. Zhang,et al.  GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency. , 2013, The Journal of clinical investigation.

[5]  J. Golledge,et al.  Everolimus Limits Aortic Aneurysm in the Apolipoprotein E–Deficient Mouse by Downregulating C-C Chemokine Receptor 2 Positive Monocytes , 2013, Arteriosclerosis, Thrombosis and Vascular Biology.

[6]  Seneca L. Bessling,et al.  Mutations in the TGF-β Repressor SKI Cause Shprintzen-Goldberg Syndrome with Aortic Aneurysm , 2012, Nature Genetics.

[7]  E. Fishman,et al.  Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm , 2012, Nature Genetics.

[8]  D. Milewicz,et al.  Rare, Nonsynonymous Variant in the Smooth Muscle-Specific Isoform of Myosin Heavy Chain, MYH11, R247C, Alters Force Generation in the Aorta and Phenotype of Smooth Muscle Cells , 2012, Circulation research.

[9]  J. Hacia,et al.  Modulation of noncanonical TGF-β signaling prevents cleft palate in Tgfbr2 mutant mice. , 2012, The Journal of clinical investigation.

[10]  P. Desgranges,et al.  Long Term Stabilization of Expanding Aortic Aneurysms by a Short Course of Cyclosporine A through Transforming Growth Factor-Beta Induction , 2011, PloS one.

[11]  G. Tellides,et al.  Activation of human vascular cells decreases their expression of transforming growth factor-beta. , 2011, Atherosclerosis.

[12]  J. Pober,et al.  Transforming Growth Factor Beta Expression by Human Vascular Cells Inhibits Interferon Gamma Production and Arterial Media Injury by Alloreactive Memory T Cells , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  Mark W Majesky,et al.  The adventitia: a dynamic interface containing resident progenitor cells. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[14]  H. Dietz,et al.  Lessons on the pathogenesis of aneurysm from heritable conditions , 2011, Nature.

[15]  J. Belmont,et al.  Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning , 2011, Proceedings of the National Academy of Sciences.

[16]  D. Milewicz,et al.  TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. , 2010, Cardiovascular research.

[17]  A. Della Corte,et al.  Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm. , 2010, Cardiovascular research.

[18]  S. Shete,et al.  Mutations in myosin light chain kinase cause familial aortic dissections. , 2010, American journal of human genetics.

[19]  Marie-José Goumans,et al.  Signaling by members of the TGF-beta family in vascular morphogenesis and disease. , 2010, Trends in cell biology.

[20]  J. Pober,et al.  CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses , 2010, The Journal of experimental medicine.

[21]  D. Milewicz,et al.  Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice. , 2010, Human molecular genetics.

[22]  D. Milewicz,et al.  Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: Evidence for a hyperplastic vasculomyopathy , 2010, Genetics in Medicine.

[23]  H. Dietz.  TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. , 2010, The Journal of clinical investigation.

[24]  Brian Bierie,et al.  Gain or loss of TGF-β signaling in mammary carcinoma cells can promote metastasis , 2009, Cell cycle.

[25]  D. Dichek,et al.  TGF-&bgr;1 Limits Plaque Growth, Stabilizes Plaque Structure, and Prevents Aortic Dilation in Apolipoprotein E–Null Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[26]  A. Al Haj Zen,et al.  Syndromic and non‐syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway , 2009, The Journal of pathology.

[27]  H. Dietz,et al.  p38 MAPK Is an Early Determinant of Promiscuous Smad2/3 Signaling in the Aortas of Fibrillin-1 (Fbn1)-null Mice* , 2009, Journal of Biological Chemistry.

[28]  M. Halushka,et al.  Histopathologic Findings in Ascending Aortas From Individuals With Loeys-Dietz Syndrome (LDS) , 2009, The American journal of surgical pathology.

[29]  V. Kaartinen,et al.  Absence of TGFβ signaling in embryonic vascular smooth muscle leads to reduced lysyl oxidase expression, impaired elastogenesis, and aneurysm , 2009, Genesis.

[30]  W. Min,et al.  MyD88-dependent, superoxide-initiated inflammation is necessary for flow-mediated inward remodeling of conduit arteries , 2008, The Journal of experimental medicine.

[31]  A. Hafezi-Moghadam,et al.  Role of TGF-β in proliferative vitreoretinal diseases and ROCK as a therapeutic target , 2008, Proceedings of the National Academy of Sciences.

[32]  J. Rosenbloom,et al.  Angiotensin II blockade in Marfan's syndrome. , 2008, The New England journal of medicine.

[33]  M. Yamashita,et al.  TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. , 2008, Molecular cell.

[34]  D. Milewicz,et al.  Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. , 2008, Annual review of genomics and human genetics.

[35]  M. Goumans,et al.  Compensatory signalling induced in the yolk sac vasculature by deletion of TGFβ receptors in mice , 2007, Journal of Cell Science.

[36]  D. Milewicz,et al.  MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. , 2007, Human molecular genetics.

[37]  Jing Qing,et al.  TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA , 2007 .

[38]  L. Luo,et al.  A global double‐fluorescent Cre reporter mouse , 2007, Genesis.

[39]  Jean-Baptiste Michel,et al.  Topological Determinants and Consequences of Adventitial Responses to Arterial Wall Injury , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[40]  V. Kaartinen,et al.  Defective ALK5 signaling in the neural crest leads to increased postmigratory neural crest cell apoptosis and severe outflow tract defects , 2006, BMC Developmental Biology.

[41]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[42]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[43]  John A Elefteriades,et al.  Hyperplastic Cellular Remodeling of the Media in Ascending Thoracic Aortic Aneurysms , 2005, Circulation.

[44]  P. Desgranges,et al.  Overexpression of Transforming Growth Factor-&bgr;1 Stabilizes Already-Formed Aortic Aneurysms: A First Approach to Induction of Functional Healing by Endovascular Gene Therapy , 2005, Circulation.

[45]  A. Verin,et al.  ALK5 and Smad4 are involved in TGF‐β1‐induced pulmonary endothelial permeability , 2005, FEBS letters.

[46]  水口 剛.  Heterozygous TGFBR2 mutations in Marfan syndrome , 2005 .

[47]  S. Karlsson,et al.  Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome. , 2005, Genes & development.

[48]  D. Carey,et al.  Rapamycin suppresses experimental aortic aneurysm growth. , 2004, Journal of vascular surgery.

[49]  D. Fingar,et al.  The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. , 2004, American journal of physiology. Cell physiology.

[50]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[51]  D. Arking,et al.  Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.

[52]  B. Nicke,et al.  Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells. , 2001, American journal of physiology. Cell physiology.

[53]  M. Goumans,et al.  Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice , 2001, The EMBO journal.

[54]  G. Owens,et al.  A Transforming Growth Factor β (TGFβ) Control Element Drives TGFβ-induced Stimulation of Smooth Muscle α-Actin Gene Expression in Concert with Two CArG Elements* , 1997, The Journal of Biological Chemistry.

[55]  M. Taketo,et al.  TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. , 1996, Developmental biology.

[56]  J. Stockman,et al.  Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice , 2012 .

[57]  M. Watkins.  TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II–infused mice , 2010 .

[58]  Stefan Offermanns,et al.  G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertension , 2008, Nature Medicine.

[59]  Jeffrey A. Jones,et al.  Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. , 2009, Journal of vascular research.

[60]  C. Ozaki.  Overexpression of Transforming Growth Factor-β1 Stabilizes Already-Formed Aortic Aneurysms: A First Approach to Induction of Functional Healing by Endovascular Gene Therapy , 2007 .